BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 6, 2001
View Archived Issues
Highlights during 2000 at Aradigm
Read More
Gemini Genomics to identify genes for depression and anxiety disorders
Read More
Xenova and Cantab provide details of merger offer and major products
Read More
NeoPharm and NCI expand collaboration for anticancer agent
Read More
Abbott acquires BASF's pharmaceutical division
Read More
Six-month trial results show Lumigan clinically superior to timolol in lowering IOP
Read More
Cell Pathways commences Aptosyn/Taxotere combination phase III trial for NSCLC
Read More
Isis and Abbott extend antisense target validation alliance
Read More
Results from two phase II trials with INS-1 in PCOS and dyslipidemia
Read More
A new class of anthelmintics identified: inhibitors of NADH-fumarate reductase
Read More
Bayer investigates seco-cyclothialidine bacterial DNA gyrase inhibitors as antibacterial agents
Read More
Broad-spectrum chemokine inhibitor is neuroprotective in rat stroke model
Read More
Malaria Vaccine Initiative and GSK to develop pediatric malaria vaccine
Read More
Aurora Biosciences and PanVera complete merger
Read More
Vivus acquires license to Tanabe Seiyaku's PDE5 inhibitor for ED
Read More
Dompe designs small-molecule IL-8 inhibitor with efficacy in animal models of I/R injury
Read More
Sustained clinical activity reported in IDEC-114 phase I/II trial for psoriasis
Read More
Phase IIa trial results presented at AAD meeting for ABX-IL-8 in psoriasis
Read More
AAD news: antipsoriatic activity of low-dose Ontak confirmed in pilot trial
Read More
European authorities designate Tracleer an orphan product for pulmonary hypertension
Read More
Gene therapy for atherosclerosis based on NOS
Read More
New angiopoietin prepared by Bayer may be useful in angiogenesis-related disorders
Read More
Peptide GLP-1 and/or exendin-4 agonists identified by Danish pharmaceutical company
Read More
New beta-lactamase inhibitors from MethylGene do not require a beta-lactam pharmacophore
Read More
Several series of Ortho-McNeil compounds reported to have neurotrophic effects
Read More
AstraZeneca claims new chemokine receptor modulators with potential therapeutic use
Read More